Condition
Falciparum
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
100%
4 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
P 3 (1)
P 4 (3)
Trial Status
Completed2
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00386750Phase 4Terminated
Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function
NCT00444106Phase 4Completed
Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function
NCT00137566Phase 4Unknown
The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau
NCT00386763Phase 3Completed
Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.
Showing all 4 trials